U.S. puts Israel on intellectual property watch list

05/2/2005 | Globes (Israel)

Israel had been off the list since 2003, but the latest priority watch list for 2005 from the U.S. Trade Representative's office cites the Mideast country, apparently because of a dispute between the two countries over Israel's protection of pharmaceutical intellectual property. The trade representative's office said progress had been made in negotiations during the past year, but Israel failed to meet U.S. demands. But Israel's chief negotiator said the watch list decision was the result of "brutal pressure" by U.S. drug companies.

View Full Article in:

Globes (Israel)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ